Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-28T08:50:26.078Z Has data issue: false hasContentIssue false

Resistance to Antibiotics in Clinical Isolates of Klebsiella pneumoniae

Published online by Cambridge University Press:  02 January 2015

Thomas F. O'Brien*
Affiliation:
Department of Medicine of the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
Kenneth H. Mayer
Affiliation:
Department of Medicine of the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
John D. Hopkins
Affiliation:
Department of Medicine of the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
John J. Farrell
Affiliation:
Department of Medicine of the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
Lee Chao
Affiliation:
Department of Medicine of the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
Ralph L. Kent
Affiliation:
Department of Medicine of the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
*
Microbiology Laboratory, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115

Abstract

The antibiotic resistance of Klebsiella pneumoniae isolates from 12 medical centers worldwide, over a 1- to 6-year period, were tested. Clinical isolates of K. pneumoniae were resistant to ampicillin and carbenicillin. Resistance to other antibiotics was less frequent with isolates of K. pneumoniae from 5 of 6 US centers than with those from 6 centers outside the US. In nearly all of the centers, resistance to sulfamethoxazole-trimethoprim, gentamicin, tobramycin, or chloramphenicol was more frequent in isolates of K. pneumoniae than in those of Escherichia coli, while the reverse was true for resistance to tetracycline. Resistance to multiple antibiotics declined gradually in isolates of K. pneumoniae at one center, but rose abruptly again with dissemination of a new plasmid.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Nugent, ME, Hedges, RW: The nature of the genetic determinant for the SHV-1 β lactamase. MGG 1979; 175:239243.Google Scholar
2. O'Brien, TF, Guzman, MA, Farreli, JA, et al: Identification of specific antibiotic resistance mechanisms from routine susceptibility testing results, in, Mitsushashi, S, Rosival, L, Kremery, V (eds): Antibiotic Resistance: Transposition and Other Mechanisms, Fourth International Symposium. New York, Springer-Verlag, 1980, pp 383388.Google Scholar
3. Atkinson, BA: Species incidence, trends of susceptibility to antibiotics in the United States, and minimum inhibitory concentration, in, Lorian, V (ed): Antibiotics in Laboratory Medicine. Baltimore, Williams & Wilkins, 1980, pp 607737.Google Scholar
4. O'Brien, TF, Ross, DG, Guzman, MA, et al: Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother 1980; 17:537543.Google Scholar
5. O'Brien, TF, Kent, RL, Medeiros, AA: Computer surveillance of shifts in the gross patient flora during hospitalization. J Infect Dis 1975; 131:8896.CrossRefGoogle ScholarPubMed
6. O'Brien, TF, Acar, JF, Medeiros, AA, et al: International comparison of prevalence of resistance to antibiotics. JAAM 1978; 239:15181523.Google Scholar